SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-24-026339
Filing Date
2024-07-05
Accepted
2024-07-05 16:06:03
Documents
7

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 285309
2 ex5-1.htm EX-5.1 10982
3 ex23-1.htm EX-23.1 3404
4 ex107.htm EX-FILING FEES 21010
5 ex5-1_001.jpg GRAPHIC 3775
6 forms-3_001.jpg GRAPHIC 3897
7 forms-3_002.jpg GRAPHIC 3897
  Complete submission text file 0001493152-24-026339.txt   338249
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-3 | Act: 33 | File No.: 333-280705 | Film No.: 241102689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)